title: Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety?
authors.affiliation: Department of Orthopaedic Surgery, Príncipe de Asturias University Hospital, Alcalá de Henares, Spain.
authors.forename: Víctor
authors.initials: V
authors.lastname: Vaquerizo
authors.affiliation: Arthroscopy Surgery Unit, Hospital Vithas San José Vitoria, Spain.
authors.forename: Mikel
authors.initials: M
authors.lastname: Sánchez
authors.affiliation: Foundation Eduardo Anitua Vitoria, Spain; BTI Biotechnology Institute Vitoria, Spain.
authors.forename: Sabino
authors.initials: S
authors.lastname: Padilla
authors.affiliation: Foundation Eduardo Anitua Vitoria, Spain.
authors.forename: Gorka
authors.initials: G
authors.lastname: Orive
authors.affiliation: Foundation Eduardo Anitua Vitoria, Spain; BTI Biotechnology Institute Vitoria, Spain.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Anitua
mesh_terms: D006801:Humans; D020370:Osteoarthritis, Knee / Q000628:therapy*